Cargando…
The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment
Breast cancer is one of the most diagnosed cancers worldwide, with an incidence of 47.8%. Its treatment includes surgery, radiotherapy, chemotherapy, and antibodies giving a mortality of 13.6%. Breast tumor development is driven by a variety of signaling pathways with high heterogeneity of surface r...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10341956/ https://www.ncbi.nlm.nih.gov/pubmed/37445915 http://dx.doi.org/10.3390/ijms241310737 |